APA (7th ed.) Citation

Alberto A. Mendivil, Paul K. Tung, Randy Bohart, Karen Bechtol, & Bram H. Goldstein. (2018). Dramatic clinical response following dabrafenib and trametinib therapy in a heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation. Elsevier.

Chicago Style (17th ed.) Citation

Alberto A. Mendivil, Paul K. Tung, Randy Bohart, Karen Bechtol, and Bram H. Goldstein. Dramatic Clinical Response Following Dabrafenib and Trametinib Therapy in a Heavily Pretreated Low Grade Serous Ovarian Carcinoma Patient with a BRAF V600E Mutation. Elsevier, 2018.

MLA (9th ed.) Citation

Alberto A. Mendivil, et al. Dramatic Clinical Response Following Dabrafenib and Trametinib Therapy in a Heavily Pretreated Low Grade Serous Ovarian Carcinoma Patient with a BRAF V600E Mutation. Elsevier, 2018.